{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:13:58Z","timestamp":1788394438563,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.remnie.2025.500129","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T11:56:25Z","timestamp":1745063785000},"page":"500129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["18F-choline PET\/CT in the study of primary hyperparathyroidism: Evaluation of the technique, visual and semi-quantitative analysis and correlation with other imaging techniques"],"prefix":"10.1016","volume":"44","author":[{"given":"E.","family":"Campa\u00f1a D\u00edaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"G\u00f3mez-Caminero L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Manuel \u00c1lvarez P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Montes Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rama Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"\u00c1ngel Badell Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Garc\u00eda-Talavera San Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.remnie.2025.500129_bib0005","doi-asserted-by":"crossref","first-page":"R441","DOI":"10.1530\/ERC-19-0135","article-title":"Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors","volume":"26","author":"Cetani","year":"2019","journal-title":"Endocr Relat Cancer."},{"issue":"9684","key":"10.1016\/j.remnie.2025.500129_bib0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet"},{"issue":"10116","key":"10.1016\/j.remnie.2025.500129_bib0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian","year":"2018","journal-title":"Lancet (London, England)."},{"issue":"10","key":"10.1016\/j.remnie.2025.500129_bib0020","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/jclinpath-2015-203186","article-title":"Clinicopathological correlates of hyperparathyroidism","volume":"68","author":"Duan","year":"2015","journal-title":"J Clin Pathol."},{"key":"10.1016\/j.remnie.2025.500129_bib0025","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg."},{"key":"10.1016\/j.remnie.2025.500129_bib0030","series-title":"Gu\u00edas cl\u00ednicas de la Sociedad Espa\u00f1ola de Cirujanos. Cirug\u00eda endocrina","first-page":"121","article-title":"Hiperparatiroidismo primario","author":"Sitges Serra","year":"2009"},{"issue":"2","key":"10.1016\/j.remnie.2025.500129_bib0035","doi-asserted-by":"crossref","first-page":"122","DOI":"10.23736\/S1824-4785.23.03512-4","article-title":"Detection, resection and cure: a systematic review and meta-analysis of 18F-choline PET in primary hyperparathyroidism","volume":"67","author":"Quak","year":"2023","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2025.500129_bib0040","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00423-009-0510-z","article-title":"Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy","volume":"394","author":"Barczynski","year":"2009","journal-title":"Langenbecks Arch Surg"},{"issue":"6","key":"10.1016\/j.remnie.2025.500129_bib0045","first-page":"351","article-title":"Contribution of early SPECT\/CT to 99mTc-MIBI double phase scintigraphy in primary hyperparathyroidism: diagnostic value and correlation between uptake and biological parameters","volume":"35","author":"Garc\u00eda-Talavera","year":"2016","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"issue":"2","key":"10.1016\/j.remnie.2025.500129_bib0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s002590000406","article-title":"99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance","volume":"28","author":"Melloul","year":"2001","journal-title":"Eur J Nucl Med."},{"key":"10.1016\/j.remnie.2025.500129_bib0055","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamaoto.2019.0574","article-title":"Usefulness of 18F-fluorocholine positron emission tomography-computed tomography in locating lesions in hyperparathyroidism: a systematic review","volume":"145","author":"Boccalatte","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.remnie.2025.500129_bib0060","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00259-018-4123-z","article-title":"Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis","volume":"46","author":"Treglia","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"10.1016\/j.remnie.2025.500129_bib0065","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/MNM.0000000000000595","article-title":"Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands","volume":"37","author":"Kluijfhout","year":"2016","journal-title":"Nucl Med Commun."},{"issue":"2S","key":"10.1016\/j.remnie.2025.500129_bib0070","article-title":"Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances","volume":"44","year":"2015","journal-title":"Ann ICRP"},{"key":"10.1016\/j.remnie.2025.500129_bib0075","first-page":"92","article-title":"Pharmacokinetics and radiation dosimetry of 18F-fluorocholine","volume":"43","author":"DeGrado","year":"2002","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1016\/j.remnie.2025.500129_bib0080","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00259-021-05334-y","article-title":"The EANM practice guidelines for parathyroid imaging","volume":"48","author":"Petranovi\u0107 Ov\u010dari\u010dek","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"12","key":"10.1016\/j.remnie.2025.500129_bib0085","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1097\/MNM.0000000000000924","article-title":"Assessment of the role of early dynamic PET\/CT with 18F-fluorocholine in detection of parathyroid lesions in patients with primary hyperparathyroidism","volume":"39","author":"Prabhu","year":"2018","journal-title":"Nucl Med Commun"},{"issue":"8","key":"10.1016\/j.remnie.2025.500129_bib0090","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/MNM.0000000000001217","article-title":"Dynamic 18F-fluorocholine PET\/CT for parathyroid imaging in patients with primary hyperparathyroidism","volume":"41","author":"Broos","year":"2020","journal-title":"Nucl Med Commun."},{"key":"10.1016\/j.remnie.2025.500129_bib0095","article-title":"PET\/TC 4D 18F-colina en el hiperparatiroidismo: correlaci\u00f3n entre datos bioqu\u00edmicos y par\u00e1metros del estudio","author":"Boccalatte","year":"2020","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"20","key":"10.1016\/j.remnie.2025.500129_bib0100","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"Declaration of Helsinki \u2013 Ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA."},{"issue":"2","key":"10.1016\/j.remnie.2025.500129_bib0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.23736\/S1824-4785.23.03514-8","article-title":"[18F]F-Choline PET\/CT and 4D-CT in the evaluation of primary hyperparathyroidism: rivals or allies?","volume":"67","author":"Fiz","year":"2023","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.remnie.2025.500129_bib0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13550-019-0544-3","article-title":"Parathyroid imaging with 18F-fluorocholine PET\/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study","volume":"9","author":"Broos","year":"2019","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.remnie.2025.500129_bib0115","article-title":"Performance of [18F]fuorocholine PET\/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent\/recurrent disease","author":"Boucher","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2025.500129_bib0120","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00259-023-06573-x","article-title":"Expanding the clinical indications of [18F]fluorocholine PET\/CT in primary hyperparathyroidism: the evidence cannot be evaded","volume":"51","author":"Treglia","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925000515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925000515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T01:57:07Z","timestamp":1756432627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808925000515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2253808925000515"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500129","relation":{},"ISSN":["2253-8089"],"issn-type":[{"value":"2253-8089","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"18F-choline PET\/CT in the study of primary hyperparathyroidism: Evaluation of the technique, visual and semi-quantitative analysis and correlation with other imaging techniques","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2025.500129","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"500129"}}